Representative before the EPO

Company dna solvias ag
no operation time available
319.93
1 office
active in Legal Services

Representative before the EPO

Company dna patentanwalt dr alexander pommerenke
no operation time available
1 office
active in Legal Services

We have observed 6 EP applications Alexander Pommerenke has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 06, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12717699

CRYSTALLINE SODIUM SALT OF AN HIV INTEGRASE INHIBITOR

IPC classification:
A61K 31/513, C07D 413/12, A61P 31/18
Applicant:
Sandoz AG
Agent:
Alexander Pommerenke, Patentanwalt Dr. Alexander Pommerenke
Status:
GRANT OF PATENT INTENDED
EP12721519

NOVEL CRYSTALLINE SALTS OF ASENAPINE

IPC classification:
A61K 31/407, C07D 491/044, A61P 25/18
Applicant:
Sandoz AG
Agent:
Alexander Pommerenke, Patentanwalt Dr. Alexander Pommerenke
Status:
EXAMINATION IN PROGRESS
EP12721518

NOVEL CRYSTALLINE SALTS OF ASENAPINE WITH ORGANIC DI-ACIDS AND TRI-ACIDS

IPC classification:
A61K 31/407, C07D 491/04, A61P 25/18
Applicant:
Sandoz AG
Agent:
Alexander Pommerenke, Patentanwalt Dr. Alexander Pommerenke
Status:
EXAMINATION IN PROGRESS
EP12720511

NOVEL CRYSTALLINE ASENAPINE HYDROCHLORIDE SALT FORMS

IPC classification:
A61K 31/407, C07D 491/044, A61P 25/18
Applicant:
Sandoz AG
Agent:
Alexander Pommerenke, Patentanwalt Dr. Alexander Pommerenke
Status:
PATENT GRANTED
EP12791764

CRYSTALLINE DAPAGLIFLOZIN HYDRATE

IPC classification:
A61K 31/351, C07D 309/10, A61P 3/10
Applicant:
Sandoz AG
Agent:
Alexander Pommerenke, Patentanwalt Dr. Alexander Pommerenke
Status:
GRANT OF PATENT INTENDED
EP13178154

Process for retanning leather

IPC classification:
C09D 175/04, C14C 11/00, C14C 9/02, C14C 3/10, C14C 3/28, C14C 3/22, C14C 3/20
Agent:
Alexander Pommerenke, Patentanwalt Dr. Alexander Pommerenke
Status:
APPLICATION REFUSED

Please Sign in to use this feature